Literature DB >> 6759276

Hormonal, metabolic and cardiovascular responses to hypoglycaemia in Type 1 (insulin-dependent) diabetes with and without residual B cell function.

S Madsbad, J Hilsted, T Krarup, L Sestoft, N J Christensen, O K Faber, B Tronier.   

Abstract

Hormonal, metabolic and cardiovascular responses to insulin induced hypoglycaemia were investigated in seven Type 1 (insulin-dependent) diabetic patients with residual B cell function, eight Type 1 diabetic patients without B cell function and six healthy subjects. No differences were found between the diabetic groups regarding nadir of glucose and rate of recovery to normoglycaemia. The patients with residual B cell function had a glucagon response to hypoglycaemia which was close to that of normal subjects. In patients without B cell function, the glucagon response to hypoglycaemia was present, albeit significantly smaller than in the patients with preserved B cell function (0.025 ng/ml, range 0.007-0.042 versus 0.054 ng/ml, range 0.029-0.087). The group without B cell function had signs of an exaggerated rate of lipolysis and ketogenesis compared with the patients with B cell function and the normal subjects.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6759276     DOI: 10.1007/bf00254298

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  24 in total

1.  [Enzymatic determination of glucose and fructose simultaneously].

Authors:  F H SCHMIDT
Journal:  Klin Wochenschr       Date:  1961-12-01

2.  Studies on the etiology of "brittle diabetes". Relationship between diabetic instability and insulinogenic reserve.

Authors:  K Shima; R Tanaka; S Morishita; S Tarui; Y Kumahara
Journal:  Diabetes       Date:  1977-08       Impact factor: 9.461

3.  A simple method for the determination of serum free insulin levels in insulin-treated patients.

Authors:  S Nakagawa; H Nakayama; T Sasaki; K Yoshino; Y Y Yu
Journal:  Diabetes       Date:  1973-08       Impact factor: 9.461

4.  Hormonal mechanisms of recovery from insulin-induced hypoglycemia in man.

Authors:  J Gerich; J Davis; M Lorenzi; R Rizza; N Bohannon; J Karam; S Lewis; R Kaplan; T Schultz; P Cryer
Journal:  Am J Physiol       Date:  1979-04

5.  Plasma noradrenaline and adrenaline in patients with thyrotoxicosis and myxoedema.

Authors:  N J Christensen
Journal:  Clin Sci Mol Med       Date:  1973-08

6.  Characterization of the glucagon response to hypoglycemia in man.

Authors:  J E Gerich; V Schneider; S E Dippe; M Langlois; C Noacco; J H Karam; P H Forsham
Journal:  J Clin Endocrinol Metab       Date:  1974-01       Impact factor: 5.958

7.  A sensitive double-isotope derivative assay for norepinephrine and epinephrine. Normal resting human plasma levels.

Authors:  K Engelman; B Portnoy
Journal:  Circ Res       Date:  1970-01       Impact factor: 17.367

Review 8.  Glucose counterregulation in man.

Authors:  P E Cryer
Journal:  Diabetes       Date:  1981-03       Impact factor: 9.461

9.  C-peptide and proinsulin after oral glucose.

Authors:  L G Heding; T Kasperska-Czyzykowa
Journal:  Acta Med Scand Suppl       Date:  1980

10.  Glucagon response to hypoglycemia in sympathectomized man.

Authors:  J P Palmer; D P Henry; J W Benson; D G Johnson; J W Ensinck
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

View more
  4 in total

1.  Prevalence of residual B cell function and its metabolic consequences in Type 1 (insulin-dependent) diabetes.

Authors:  S Madsbad
Journal:  Diabetologia       Date:  1983-03       Impact factor: 10.122

2.  Improved but not normalized glucose counter-regulation during glucagon infusion in Type 1 (insulin-dependent) diabetes.

Authors:  I Lager; H von Schenck; U Smith
Journal:  Diabetologia       Date:  1984-05       Impact factor: 10.122

3.  Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man. Role of the beta cell and arterial hyperinsulinemia.

Authors:  G Bolli; P De Feo; G Perriello; S De Cosmo; P Compagnucci; F Santeusanio; P Brunetti; R H Unger
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

4.  High residual C-peptide likely contributes to glycemic control in type 1 diabetes.

Authors:  Michael R Rickels; Carmella Evans-Molina; Henry T Bahnson; Alyssa Ylescupidez; Kristen J Nadeau; Wei Hao; Mark A Clements; Jennifer L Sherr; Richard E Pratley; Tamara S Hannon; Viral N Shah; Kellee M Miller; Carla J Greenbaum
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.